[Androgen deprivation therapy for prostate cancer and osteoporotic risk].

Androgen deprivation therapy represents an important part of the management of prostate cancer. However, epidemiological data have shown that it is a well-established cause of osteoporosis and increased risk of fracture. So far no consensus guidelines have been published regarding the screening and treatment of osteoporosis in men with prostate cancer.

[Value of the use of a questionnaire in the evaluation of incontinence surgery].

Objective: To assess the contribution of a questionnaire in the evaluation of patients operated for urinary stress incontinence.

Patients And Methods: From 1988 to 1996, 42 patients underwent bladder neck suspension for urinary stress incontinence. Only 7 patients had no history of pelvic surgery, 24 patients presented pure urinary stress incontinence and 19 presented mixed incontinence, 37 patients were evaluable with a mean follow-up of 2 years.

Diagnostic value of ten systematic TRUS-guided prostate biopsies.

Objective: To evaluate the improvement in the rate of detection of prostate cancer using an extensive protocol involving ten transrectal biopsies.

Methods: A total of 162 patients submitted to transrectal ultrasound-guided biopsy for elevated prostate-specific antigen (PSA) and/or abnormality on digital rectal examination were studied consecutively and prospectively. Five biopsies were performed in each lobe: between the three standard biopsies on each side, two additional biopsy specimens were taken in the same plane and at the same 45 degrees angle.

Urolithiasis and the protease inhibitor indinavir.

Objective: To evaluate specific urological abnormalities in patients treated with the protease inhibitor indinavir.

Methods: A series of 155 consecutive human immunodeficiency virus-positive patients were treated with indinavir 800 mg p.o.